Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus co-infection
H Kovari, B Ledergerber, M Battegay… - Clinical infectious …, 2010 - academic.oup.com
Background. Chronic liver disease in human immunodeficiency virus (HIV)–infected patients
is mostly caused by hepatitis virus co-infection. Other reasons for chronic alanine …
is mostly caused by hepatitis virus co-infection. Other reasons for chronic alanine …
[PDF][PDF] Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta‐analysis of the risk factors
MV Machado, AG Oliveira, H Cortez‐Pinto - Hepatology, 2010 - Wiley Online Library
Hepatic steatosis (HS) is frequent in patients with hepatitis C virus (HCV) infection, occurring
in 40%‐80%, associating with metabolic and virus‐related factors, namely, genotype 3 and …
in 40%‐80%, associating with metabolic and virus‐related factors, namely, genotype 3 and …
HIV infection: an independent risk factor of peripheral arterial disease
Y Ye, Y Zeng, X Li, S Zhang, Q Fang… - JAIDS Journal of …, 2010 - journals.lww.com
To the Editors: Highly active antiretroviral therapy (HAART) had significantly reduced the
death rate resulted from HIV infection. However, HAART had also increased the risk of …
death rate resulted from HIV infection. However, HAART had also increased the risk of …
Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons
Objective: To evaluate the relationship between regional body composition and liver
disease (fibrosis or steatosis) in HIV/HCV co-infected individuals. Methods: Whole body dual …
disease (fibrosis or steatosis) in HIV/HCV co-infected individuals. Methods: Whole body dual …
Nonalcoholic fatty liver disease in HIV-infected persons: epidemiology and the role of nucleoside reverse transcriptase inhibitors
G Guaraldi, C Stentarelli, G Orlando… - JAIDS Journal of …, 2010 - journals.lww.com
To the Editors: Highly active antiretroviral therapy (HAART) had significantly reduced the
death rate resulted from HIV infection. However, HAART had also increased the risk of …
death rate resulted from HIV infection. However, HAART had also increased the risk of …
[PDF][PDF] Human immunodeficiency virus and liver disease: conference proceedings
Liver disease has emerged as one of the major causes of morbidity and mortality among
patients infected with the human immunodeficiency virus (HIV), particularly in regions where …
patients infected with the human immunodeficiency virus (HIV), particularly in regions where …
Reply to “Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons “
N Crum-Cianflone, A Dilay, G Collins… - JAIDS Journal of …, 2010 - journals.lww.com
We appreciate the interest of Guaraldi et al in our recent article on nonalcoholic fatty liver
disease (NAFLD) among HIV-infected persons. 1 Both our study and a recent article by their …
disease (NAFLD) among HIV-infected persons. 1 Both our study and a recent article by their …